Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Granisetron hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for granisetron hydrochloride and what is the scope of granisetron hydrochloride patent protection?

Granisetron hydrochloride
is the generic ingredient in four branded drugs marketed by Roche, Sandoz Inc, West-ward Pharms Int, Taro Pharm, Akorn Inc, Barr, Fresenius Kabi Usa, Mylan, Hikma Farmaceutica, Pediatrx, Sagent Strides, Sagent Agila, Cipla Ltd, Aurobindo Pharma Ltd, Apotex Inc, Dr Reddys Labs Ltd, Mylan Labs Ltd, Corepharma, Bionpharma Inc, Teva Pharms Usa, Wockhardt Usa, Natco Pharma, Luitpold, Orchid Hlthcare, Teva Pharms, and Claris, and is included in forty-eight NDAs. There are two patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Granisetron hydrochloride has twenty-five patent family members in nineteen countries.

There are twenty-six drug master file entries for granisetron hydrochloride. Eighteen suppliers are listed for this compound.

Summary for Generic Name: granisetron hydrochloride

Tradenames:4
Patents:2
Applicants:26
NDAs:48
Drug Master File Entries: see list26
Suppliers / Packagers: see list18
Bulk Api Vendors: see list62
Clinical Trials: see list1,021
Patent Applications: see list2,379
Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:granisetron hydrochloride at DailyMed

Pharmacology for Ingredient: granisetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orchid Hlthcare
GRANISETRON HYDROCHLORIDE
granisetron hydrochloride
TABLET;ORAL078678-001Feb 13, 2008ABRXNoNo► Subscribe► Subscribe
Natco Pharma
GRANISETRON HYDROCHLORIDE
granisetron hydrochloride
TABLET;ORAL078969-001Jun 22, 2009ABRXNoNo► Subscribe► Subscribe
Akorn Inc
GRANISETRON HYDROCHLORIDE
granisetron hydrochloride
INJECTABLE;INJECTION079078-001Sep 14, 2009APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
granisetron hydrochloride
INJECTABLE;INJECTION078096-001Jun 30, 2008APRXNoYes► Subscribe► Subscribe
Hikma Farmaceutica
GRANISETRON HYDROCHLORIDE
granisetron hydrochloride
INJECTABLE;INJECTION078629-002Dec 23, 2009APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot